WaferGen to Raise $1.5M in Private Financing | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems has inked a deal to raise $1.5 million through a private placement of shares in its Malaysian subsidiary, WaferGen Biosystems Sdn. Bhd.

Investors in the round included Prima Mahawangsa, which is a wholly owned subsidiary of CAV Private Equity Management, and Expedient Equity Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.